We are research. We are biosyn, a health-driven biotech and pharmaceutical company. The promotion of a healthy immune system is the elemental philosophy behind every product we develop. One of the first biotechnology corporations in Germany, we are located in its Pharma Heartland Baden-Wuerttemberg. Our motto "We are research" has driven a rich number of pioneering discoveries in pharmaceuticals and dietary supplements since 1984. We are trace element specialists and lead the world in the market for high-dose selenium injections. The name biosyn is synonymous with forward-looking advancements in immunological medicine. Our focus is on the development of manufacturing processes for immunologically active pharmaceutical ingredients (APIs) and equally on clinical research into their benefits for human well-being. Since its founding, this family-owned enterprise has been committed to finding optimal solutions in dynamic ways. For biosyn, clinical studies are pivotal: most studies on selenium in sepsis, oncology, reperfusion, cardiac surgery etc. worldwide are performed with selenase, its medicinal selenium product. biosyn boasts clean room manufacturing in compliance with Good Manufacturing Practice (cGMP). Its proprietary purification and crystallization technologies allow the sterile production of other high-quality trace element compounds too. We are proudly one of the few producers of a unique immunomodulator called keyhole limpet hemocyanin (KLH), derived from the marine mollusk Megathura crenulata. Our pride in helping fight cancer and diseases like Alzheimer is comparatively as big as the KLH protein molecule - so efficacious with few side effects. Our blockbusters selenase, containing medicinal selenium and IMMUCOTHEL, containing KLH, have been benefiting health for over 3 decades in over 27 countries. Like to be part of something vibrant and extraordinary that gives back to humanity? Explore our website, join us to bring your passion for health to life.
View Top Employees from biosyn Arzneimittel GmbHWebsite | https://www.biosyn.de |
Revenue | $12 million |
Employees | 34 (23 on RocketReach) |
Founded | 1984 |
Address | Schorndorfer Strasse 32, Fellbach, Baden-Württemberg 70734, DE |
Phone | +49 711 5753200 |
Technologies | |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
Web Rank | 1 Million |
Keywords | Biosyn, Selenase 200 Xxl Tabletten, Ab Welchem Messwert Ist Ein Imunsystem Schwach, Selen Überdosierung, Seleen |
SIC | SIC Code 821 Companies, SIC Code 82 Companies |
NAICS | NAICS Code 611110 Companies, NAICS Code 611 Companies, NAICS Code 61 Companies, NAICS Code 61111 Companies, NAICS Code 6111 Companies |
Looking for a particular biosyn Arzneimittel GmbH employee's phone or email?
The biosyn Arzneimittel GmbH annual revenue was $12 million in 2024.
Fatma Demir is the Head of Product Development of biosyn Arzneimittel GmbH.
23 people are employed at biosyn Arzneimittel GmbH.
biosyn Arzneimittel GmbH is based in Fellbach, Baden-Württemberg.
The NAICS codes for biosyn Arzneimittel GmbH are [611110, 611, 61, 61111, 6111].
The SIC codes for biosyn Arzneimittel GmbH are [821, 82].